Skip to main content
OpenTrials
Completed

NCT Number: NCT02092740

REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg

Retrospective analysis of treatment outcome and side effects of testicular cancer patients that had been diagnosed at the University Magdeburg from 1960 until 2012.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Testicular Cancer Endocrine Gland Neoplasms Endocrine System Diseases Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Gonadal Disorders Male Urogenital Diseases Neoplasms Neoplasms by Site Testicular Diseases Testicular Neoplasms Urogenital Diseases Urogenital Neoplasms

Sex eligibility

Male

Study type

Observational

Primary location

Urology University Magdeburg

Magdeburg, Saxony-Anhalt, 39120, Germany

About this study

Creating an ACCESS Windows form based Data Registry for testicular cancer patients.

Relevant data for testicular cancer patients based on EAU-guidelines 2013 and EORTC/RTOG, Lent-SOMA, CTC. All testicular cancer patients who had been histopathologically diagnosed al the Institute of Pathology at the University Magdeburg. About 2000 patients from 1960 until 2012. Postgraduate students collecting data requesting hospital documents, cancer registry of Sachsen-Anhalt, family practitioners and urologists as well as patients. Statistically Analysis with ACCESS and IBM SPSS statistics.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • testicular cancer histopathologically diagnosed at the University Magdeburg Germany

Exclusion criteria

  • none.

Treatment and study plan

Primary outcomes

  1. Overall survival (OS)

    Time frame: Up to 52 years.

    Overall survival (OS).

Secondary outcomes

  1. Disease-specific survival.

    Time frame: Up to 52 years.

    Disease-specific survival of testicular cancer.

  2. Chronic side effects of testicular-cancer-specific radiation therapies.

    Time frame: Up to 52 years.

    All Therapy Associated side effects of radiation therapy using EORTC (European Organisation for Research and Treatment of Cancer) /RTOG- (Radiation Therapy Oncology Group) - RTOG/EORTC Late Radiation Morbidity Scoring Schema), LENT-SOMA-(Late Effects of Normal Tissues)-, CTCAE-(Common Terminology Criteria for Adverse Events V4)-Scores. See

  3. Chronic side effects of testicular-cancer-specific chemotherapies.

    Time frame: Up to 52 years.

    All Therapy Associated side effects of chemotherapy using CTCAE-(Common Terminology Criteria for Adverse Events V4)-Score.

  4. Chronic side effects of testicular-cancer-specific surgical therapies.

    Time frame: Up to 52 years.

    All Therapy Associated side effects of surgical therapy using CTCAE-(Common Terminology Criteria for Adverse Events V4)-Score.

  5. Secondary Malignoma

    Time frame: Up to 52 years.

    Assessment of Development of Secondary malignoma after diagnosis of testicular cancer; Secondary malignoma other than testicular cancer and metachronous Primary testicular cancer

  6. Progressive-free survival (PFS).

    Time frame: Up to 52 years.

    Progressive-free survival (PFS).

  7. Relapse-free survival (RLS).

    Time frame: Up to 52 years.

    Relapse-free survival (RLS).

  8. Quality of Life (QoL).

    Time frame: Current situation.

    Assessment of the current QoL using ECOG and EORTC-QLQ-C30-V3D.

  9. Cause of death.

    Time frame: Up to 52 years.

    Cause of death.

Sponsors and collaborators

Lead sponsor

University of Magdeburg

Other

Registry information

Official study title

Retrospective Analysis of Testicular Cancer Patients With Histopathological Analysis or Urological Treatment at the University Magdeburg 1960-2012.

Acronym: RETESTICAPUM

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Mar 20, 2014
Registry last updated
Mar 24, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.